- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01993368
Analysis of Osteoimmune Interactions Linking Inflammation and Bone Destruction in Aggressive Periodontitis (PAG)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Context: Periodontitis are inflammatory diseases affecting the periodontium and characterized by the destruction of the tooth-supporting bone due to increased bone resorption by osteoclasts (OCLs). Two forms are described: chronic periodontitis (CP) and aggressive periodontitis (AP) that differ by the severity and rapidity of bone loss, much more important for AP than CP. In both forms, the link with uncontrolled activation of the immune system is largely admitted. But despite the physiopathology of CP is fairly well studied, very few data are available regarding AP. Based on the investigators previous studies, their hypothesis to explain this severity is the existence of a vicious circle involving immune cells, mesenchymal cells and OCLs, that would maintain and amplify inflammation and bone loss.
Study: this is a transversal, interventional and single-center study. It includes 3 groups of 20 patients: affected with AP, CP or controls (necessitating an extraction of wisdom teeth).
Aims: the investigators will compare the proportion of immune and mesenchymal cells in the 3 groups of patients to identify the populations potentially involved in bone destruction. The investigators will compare in vitro their capacity to induce OCL differentiation in order to determine their role in bone loss. The investigators will also compare the capacity of OCLs and mesenchymal cells to activate T cells, in order to determine their role in inflammation.
Methodology: patients will be recruited in the department of periodontology, CHU of Nice. After signing the informed consent, a biopsy of periodontal granulation tissue (surgical waste) will be collected during the usual treatment of these diseases, as well as a blood sample. Then, patients will leave the study. Cells from the biopsies will be analyzed by flow cytometry to determine the proportion of lymphocytic, monocytic and mesenchymal cells. In vitro, their capacity to induce OCL differentiation or to activate T cells will be determined. From the blood samples, OCLs will be generated to study their capacity to activate T cells.
Chronology of consultations and examinations: 3 visits are planned: (1) a routine visit corresponding to the usual treatment of the patient during which it is proposed to participate in the study, (2) a visit to obtaining consent, clinical examination, criteria verification and (3) a visit corresponding to the usual treatment in which will be collected tissue biopsies and blood.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nice, France, 06000
- Odontology Department, Nice Unversity Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criterias for agressive periodontits
- Young patients not suffering of any médical conditions
- Small amount of calculus detected
- Pocket depth >5mm
- Alveolar Bone loss >50%
Inclusion criterias for chronic periodontitis
- Evident presence of calculus above or under the gingiva
- Pocket depth >5mm
Inclusion criterias for control patients :
- Young patients in need of impacted wisdom teeth removal
- And not suffering of chronic or agressive periodontitis
Exclusion criterias :
- Patients with blood disorder
- Patients presenting with liver, kidney, or vascular disorder, and /or psychiatric disorder
- Patients who have allergies
- Patients taking biphosphonates, anticoagulant drugs, or anticonvulsivant
- Patients who have had a cancer of the mouth, and/or treated by radiotherapy
- Patients who have taken anti-inflammatory drugs, and/or anti-cancer drugs, and/or immuno-suppresive drugs in the past 6 months
- Patients who have had a periodontal treatment in the past 12 months
- Pregnant Women
- Patients juged difficult to follow by the investigator
- Vulnerable patients
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: chronic periodontitis
biopsy of periodontal granulation tissue (surgical waste)
|
These populations will be identified by different combinations of antibodies to identify:
Other Names:
|
|
Other: aggressive periodontitis (AP)
biopsy of periodontal granulation tissue (surgical waste)
|
These populations will be identified by different combinations of antibodies to identify:
Other Names:
|
|
Other: controls
necessitating an extraction of wisdom teeth
|
These populations will be identified by different combinations of antibodies to identify:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
proportion of lymphocytes, myeloid and mesenchymal populations in the samples
Time Frame: At the surgery time
|
determined by flow cytometry
|
At the surgery time
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jérôme SURMENIAN, MD, Odontology Department, NIce University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-PP-07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aggressive Periodontitis
-
Tokat Gaziosmanpasa UniversityCompletedChronic Periodontitis | Localized Aggressive PeriodontitisTurkey
-
Universidade Estadual Paulista Júlio de Mesquita...UnknownAggressive Periodontitis, Generalized
-
Istanbul UniversityCompletedPeriodontitis, AggressiveTurkey (Türkiye)
-
Asem Mohammed Kamel AliCompletedMolar-incisor Pattern Grade C Periodontitis ( Localized Aggressive Periodontitis) | Generalized Grade C Periodontitis (Generalized Aggressive Periodontitis)Egypt
-
Peking UniversityCompletedAggressive Periodontitis, GeneralizedChina
-
University of Campinas, BrazilCompletedGeneralized Aggressive Periodontitis
-
University of Campinas, BrazilCompletedGeneralized Aggressive Periodontitis
-
Universidade Estadual Paulista Júlio de Mesquita...CompletedAggressive Periodontitis, GeneralizedBrazil
-
Al-Azhar UniversityCompletedLocalized Aggressive Periodontitis
-
Kocaeli UniversityCompletedGeneralized Aggressive Periodontitis
Clinical Trials on flow cytometry
-
Omnia Ahmed Nafea MohamedNot yet recruitingHashimoto's Thyroiditis
-
Assiut UniversityNot yet recruitingLymphoproliferative Disorders
-
The First Affiliated Hospital of Soochow UniversityNot yet recruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingLymphoma | Hemophagocytic LymphohistiocytosesItaly
-
Centre Hospitalier Universitaire, AmiensRecruitingMyelodysplastic SyndromesFrance
-
University Hospital, IoanninaCompleted
-
Beckman Coulter, Inc.CompletedLeukemia-LymphomaCanada, United States, Germany
-
University Hospital, Strasbourg, FranceNot yet recruiting
-
Maastricht UniversityMaastricht University Medical Center; Zuyderland Medisch CentrumNot yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myelodysplastic Syndrome/Neoplasm
-
Beckman Coulter, Inc.The First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaboratorsCompletedHematologic Diseases | Hematologic Neoplasms | Hematologic MalignancyChina